BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7075677)

  • 1. Comparison of soluble dopamine D2-receptors from three species.
    Madras BK; Davis A; Seeman P
    Eur J Pharmacol; 1982 Mar; 78(4):431-8. PubMed ID: 7075677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of binding sites for [3H]spiroperidol.
    Luedtke RR; Molinoff PB
    Biochem Pharmacol; 1987 Oct; 36(19):3255-64. PubMed ID: 2959288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of an affinity chromatography matrix for the selective purification of the dopamine D2 receptor from bovine striatal membranes.
    Clagett-Dame M; Schoenleber R; Chung C; McKelvy JF
    Biochim Biophys Acta; 1989 Nov; 986(2):271-80. PubMed ID: 2531613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solubilization of dopamine-D2 receptors from synaptosomal membranes of the bovine caudate nucleus.
    Kidric M; Petrović J; Soskić V; Trajković D
    Br J Pharmacol; 1984 Nov; 83(3):687-95. PubMed ID: 6509260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of membrane-bound and soluble D2 receptors in canine caudate using [125I]IBZM.
    Schonwetter BS; Luedtke RR; Kung MP; Billings J; Kung HF; Molinoff PB
    J Pharmacol Exp Ther; 1989 Jul; 250(1):110-6. PubMed ID: 2526213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine D1 receptors characterized with [3H]SCH 23390. Solubilization of a guanine nucleotide-sensitive form of the receptor.
    Niznik HB; Otsuka NY; Dumbrille-Ross A; Grigoriadis D; Tirpak A; Seeman P
    J Biol Chem; 1986 Jun; 261(18):8397-406. PubMed ID: 3522568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of rat striatal dopamine D-1 receptors solubilized by digitonin with a precipitation method.
    Zhang X; Segawa T
    Eur J Pharmacol; 1989 Aug; 166(3):401-10. PubMed ID: 2680521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the binding of [3H]spiperone and [3H]domperidone in homogenates of mammalian retina and caudate nucleus.
    Watling KJ; Iversen LL
    J Neurochem; 1981 Nov; 37(5):1130-43. PubMed ID: 7299392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement in conditions for solubilisation and characterisation of brain D2 dopamine receptors using various detergents.
    Wheatley M; Hall JM; Frankham PA; Strange PG
    J Neurochem; 1984 Oct; 43(4):926-34. PubMed ID: 6470714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solubilization of neuroleptic/dopamine receptors of human brain striatum.
    Davis A; Madras B; Seeman P
    Eur J Pharmacol; 1981 Mar; 70(3):321-9. PubMed ID: 6112153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine agonist high-affinity state in solubilized D2 receptors in striatum, but not in anterior pituitary.
    Dumbrille-Ross A; Seeman P
    Biochem Pharmacol; 1987 Jul; 36(13):2095-9. PubMed ID: 2955789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solubilization of D2 dopamine receptor coupled to guanine nucleotide regulatory protein from bovine striatum.
    Kuno T; Saijoh K; Tanaka C
    J Neurochem; 1983 Sep; 41(3):841-7. PubMed ID: 6308173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro binding of the very potent and selective D-2 dopamine agonist, [3H]N-0437 to calf caudate membranes.
    Van der Weide J; De Vries JB; Tepper PG; Horn AS
    Eur J Pharmacol; 1987 Feb; 134(2):211-9. PubMed ID: 3569410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of dopamine D2 receptors with a zwitterionic detergent DCHAPS.
    Soskić V; Petrović J
    Biochem Pharmacol; 1986 Dec; 35(23):4229-36. PubMed ID: 2947577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors.
    Closse A; Frick W; Markstein R; Maurer R; Nordmann R
    J Neural Transm; 1985; 62(3-4):231-48. PubMed ID: 3161996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.
    Seeman P; Woodruff GN; Poat JA
    Eur J Pharmacol; 1979 Apr; 55(2):137-42. PubMed ID: 456412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2- but not D3-dopamine receptors detected in the anterior pituitary.
    Titeler M; Van Loon GR; Seeman P; Brown GM
    Eur J Pharmacol; 1981 Apr; 71(1):143-6. PubMed ID: 7238583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of dopamine autoreceptor and [3H]spiperone binding sites in vitro with classical and novel dopamine receptor agonists.
    Lehmann J; Briley M; Langer SZ
    Eur J Pharmacol; 1983 Mar; 88(1):11-26. PubMed ID: 6133762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solubilized receptors for [3H]dopamine (D3 binding sites) from canine brain.
    Davis A; Madras BK; Seeman P
    Biochem Pharmacol; 1982 Apr; 31(7):1183-7. PubMed ID: 7092913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solubilization of multiple binding sites for the dopamine receptor from calf striatal membranes.
    Clement-Cormier YC; Meyerson LR; McIsaac A
    Biochem Pharmacol; 1980 Jul; 29(14):2009-16. PubMed ID: 7406913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.